# Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo

> **NCT01426269** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 235 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** Doxycycline
- **DRUG:** Metronidazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01426269
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 235 (ACTUAL)
- **Last updated:** 2022-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01426269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01426269, "Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01426269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*